Margaret Ancona - 03 Nov 2025 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: EVP, Strategy & Transformation
Signature: By: Justin Hunter For: Margaret Ancona
Issuer symbol: MYGN
Transactions as of: 03 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Nov 2025, 16:32:46 UTC
Previous filing: 22 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ancona Margaret	EVP, Strategy & Transformation	322 NORTH 2200 WEST, SALT LAKE CITY	By: Justin Hunter For: Margaret Ancona	04 Nov 2025	0001843568

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						127,726	03 Nov 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Margaret Ancona is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that, effective on November 3, 2025, the Reporting Person no longer serves in the role of EVP, Strategy & Transformation of the Company, and therefore is no longer subject to Section 16 reporting.